Previous studies showed that autophagy activation inhibited tumor progression by suppressing the inflammatory response [38], so we investigated the relationship between SPAG9 and the inflammatory response in ccRCC and BLCA. This evidence concerns the gene SPAG9 and nonpapillary renal cell carcinoma.